Brand Description
TECVAYLI® is a bispecific T-cell engager treatment for adult patients with relapsed or refractory multiple myeloma, approved under accelerated conditions due to its efficacy in prior therapy-resistant cases.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Medical and BiotechnologyHealth and Medical Services
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|---|---|---|---|---|---|---|---|---|---|---|
| cml4kl | PP | $6.00 | 2/2/2026, 2:47:57 AM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 320x50 | 8/10 | 774.57 KB | 7459.00 ms |